Trial Profile
Efficacy of neoadjuvant imatinib in patients with gastrointestinal stromal tumours of the rectum
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Adverse reactions; Therapeutic Use
- 22 Sep 2015 New trial record
- 01 Jul 2015 Results published in the British Journal of Surgery.